Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved..

BACKGROUND: Endocrine disruptors (EDs) have emerged as potential contributors to the development of type-2 diabetes. Perfluorooctane sulfonate (PFOS), is one of these EDs linked with chronic diseases and gathered attention due to its widespread in food.

OBJECTIVE: To assess at baseline and after 1-year of follow-up associations between estimated dietary intake (DI) of PFOS, and glucose homeostasis parameters and body-mass-index (BMI) in a senior population of 4600 non-diabetic participants from the PREDIMED-plus study.

METHODS: Multivariable linear regression models were conducted to assess associations between baseline PFOS-DI at lower bound (LB) and upper bound (UB) established by the EFSA, glucose homeostasis parameters and BMI.

RESULTS: Compared to those in the lowest tertile, participants in the highest tertile of baseline PFOS-DI in LB and UB showed higher levels of HbA1c [β-coefficient(CI)] [0.01 %(0.002 to 0.026), and [0.06 mg/dL(0.026 to 0.087), both p-trend ≤ 0.001], and fasting plasma glucose in the LB PFOS-DI [1.05 mg/dL(0.050 to 2.046),p-trend = 0.022]. Prospectively, a positive association between LB of PFOS-DI and BMI [0.06 kg/m2(0.014 to 0.106) per 1-SD increment of energy-adjusted PFOS-DI was shown. Participants in the top tertile showed an increase in HOMA-IR [0.06(0.016 to 0.097), p-trend = 0.005] compared to participants in the reference tertile after 1-year of follow-up.

DISCUSSION: This is the first study to explore the association between DI of PFOS and glucose homeostasis. In this study, a high baseline DI of PFOS was associated with a higher levels of fasting plasma glucose and HbA1c and with an increase in HOMA-IR and BMI after 1-year of follow-up.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:186

Enthalten in:

Environment international - 186(2024) vom: 25. Apr., Seite 108565

Sprache:

Englisch

Beteiligte Personen:

Khoury, Nadine [VerfasserIn]
Ángeles Martínez, María [VerfasserIn]
Nishi, Stephanie K [VerfasserIn]
Ángel Martínez-González, Miguel [VerfasserIn]
Corella, Dolores [VerfasserIn]
Castañer, Olga [VerfasserIn]
Alfredo Martínez, J [VerfasserIn]
Alonso-Gómez, Ángel M [VerfasserIn]
Wärnberg, Julia [VerfasserIn]
Vioque, Jesús [VerfasserIn]
Romaguera, Dora [VerfasserIn]
López-Miranda, José [VerfasserIn]
Estruch, Ramon [VerfasserIn]
Tinahones, Francisco J [VerfasserIn]
Manuel Santos-Lozano, José [VerfasserIn]
Serra-Majem, Lluís [VerfasserIn]
Bueno-Cavanillas, Aurora [VerfasserIn]
Tur, Josep A [VerfasserIn]
Cinza Sanjurjo, Sergio [VerfasserIn]
Pintó, Xavier [VerfasserIn]
Juan Gaforio, José [VerfasserIn]
Matía-Martín, Pilar [VerfasserIn]
Vidal, Josep [VerfasserIn]
Vázquez, Clotilde [VerfasserIn]
Daimiel, Lidia [VerfasserIn]
Ros, Emilio [VerfasserIn]
Sayon-Orea, Carmen [VerfasserIn]
V Sorli, Jose [VerfasserIn]
Pérez-Vega, Karla-Alejandra [VerfasserIn]
Garcia-Rios, Antonio [VerfasserIn]
Ortiz-Díaz, Francisco [VerfasserIn]
Gómez-Gracia, Enrique [VerfasserIn]
Zulet, M A [VerfasserIn]
Chaplin, Alice [VerfasserIn]
Casas, Rosa [VerfasserIn]
Salcedo-Bellido, Inmaculada [VerfasserIn]
Tojal-Sierra, Lucas [VerfasserIn]
Bernal-Lopez, Maria-Rosa [VerfasserIn]
Vazquez-Ruiz, Zenaida [VerfasserIn]
Asensio, Eva M [VerfasserIn]
Goday, Albert [VerfasserIn]
Peña-Orihuela, Patricia J [VerfasserIn]
Signes-Pastor, Antonio J [VerfasserIn]
Garcia-Arellano, Ana [VerfasserIn]
Fitó, Montse [VerfasserIn]
Babio, Nancy [VerfasserIn]
Salas-Salvadó, Jordi [VerfasserIn]

Links:

Volltext

Themen:

9H2MAI21CL
Alkanesulfonic Acids
Blood Glucose
Diabetes
Dietary intake
Endocrine Disruptors
Endocrine disruptors (EDs)
Environmental Pollutants
Fluorocarbons
Glucose homeostasis parameters
Journal Article
Perfluorooctane sulfonate (PFOS)
Perfluorooctane sulfonic acid
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 24.04.2024

Date Revised 24.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.envint.2024.108565

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370638255